88. Chronic thromboembolic pulmonary hypertension Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 157 / Drugs : 107 - (DrugBank : 22) / Drug target genes : 14 - Drug target pathways : 54
Chronic thromboembolic pulmonary hypertension and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
88 | Chronic thromboembolic pulmonary hypertension |
86 | Pulmonary arterial hypertension |
51 | Scleroderma |
13 | Multiple sclerosis/Neuromyelitis optica |
85 | Idiopathic interstitial pneumonia |
84 | Sarcoidosis |
46 | Malignant rheumatoid arthritis |
6 | Parkinson disease |
91 | Budd-Chiari syndrome |
87 | Pulmonary veno-occlusive disease |
8 | Huntington disease |
96 | Crohn disease |
47 | Buerger disease |
89 | Lymphangioleiomyomatosis |
225 | Congenital nephrogenic diabetes insipidus |
210 | Single Ventricle |
162 | Pemphigoid |
66 | IgA nephropathy |
58 | Hypertrophic cardiomyopathy |
34 | Neurofibromatosis |
299 | Cystic fibrosis |
49 | Systemic lupus erythematosus |
97 | Ulcerative colitis |
35 | Pemphigus |